American Healthcare REIT drops on commencing stock offering
** Shares of American Healthcare REIT AHR.N down 4.4% at $23.45 in after hours trading on news of equity offering
** Irvine, California-based firm commences 14.5 mln share offering
** Co expects to use net proceeds to exercise its option to purchase its joint venture partner's 24% minority interest in Trilogy Holdings, LLC and repay some debt
** BofA, Morgan Stanley and KeyBanc jt bookrunners for offering
** AHR owns clinical healthcare properties, focusing on medical office buildings, skilled nursing and senior housing facilities
** In Feb, AHR went public after selling 56 mln shares in IPO priced at $12
** Co has ~132.86 mln shares outstanding as of Sept 13
** Shares on Weds closed up 0.9% at $24.53
(Lance Tupper is a Reuters market analyst. The views expressed are his own)
</body></html>Latest News
Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.
All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.
Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.
